Microsoft
MSFT
MARA Holdings
MARA
Meta Platforms
META
4
Oracle
ORCL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
ZVSA ZyVersa Therapeutics
- 0.6099
- 0.00000.00%
Trading May 1 10:50 ET
2.21MMarket Cap-0.07P/E (TTM)
0.6163High0.5860Low78.14KVolume0.5900Open0.6099Pre Close46.43KTurnover2.16%Turnover RatioLossP/E (Static)3.62MShares6.685552wk High0.26P/B2.20MFloat Cap0.551652wk Low--Dividend TTM3.61MShs Float8750.0000Historical High--Div YieldTTM4.97%Amplitude0.5516Historical Low0.5940Avg Price1Lot Size
ZyVersa Therapeutics Key Stats
EPS
According to the latest financial report of ZyVersa Therapeutics, the latest earnings per share (TTM) for the company is -0.57. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about ZyVersa Therapeutics's free cash flow? The latest report shows it as -1.22M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ZyVersa Therapeutics shows that the company's current ratio is 0.15, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ZyVersa Therapeutics, the quick ratio is 0.14, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of ZyVersa Therapeutics? The latest ROE figure is -18.29%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ZyVersa Therapeutics, the total asset return on investment (ROA) is -7.10%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ZyVersa Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ZyVersa Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀